Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04926857 · ClinicalTrials.gov registry record
DEFINE AFib (Atrial Fibrillation)
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 973
- Enrollment target
NCT04926857 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 973 participants.
The verdict
NCT04926857 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 973 participants
- Enrollment target
Study Summary
DEFINE AFib is a prospective, observational, post-market clinical study administered to patients via the Medtronic Discovery app platform. This study will enroll approximately 5,000 patients in the United States who have a Reveal LINQ or LINQ II ICM (or future market-released LINQ devices) and an Apple® iPhone® with iOS version 13 or higher. Interested participants will be screened through the Medtronic Discovery app and those eligible will complete an app-based informed consent. Participants will receive health-focused and quality of life surveys at variable timepoints. DEFINE AFib will measure healthcare interactions using administered surveys to identify said interactions. The Medtronic Discovery app will provide participants with a summary of their ICM data. Participants will be followed up to 5 years or to the end of their ICM service life.
Interventions
- OTHER Non-Interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 973 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2024-01-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04926857
The ClinicalTrials.gov registry entry for NCT04926857 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 973 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional is the first listed.
NCT04926857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04926857 about?
NCT04926857 is a clinical study titled "DEFINE AFib (Atrial Fibrillation)". DEFINE AFib is a prospective, observational, post-market clinical study administered to patients via the Medtronic Discovery app platform. This study will enroll approximately 5,000 patients in the United States who have a Reveal LINQ or LINQ II ICM (or future market-released LINQ devices) and an Ap...
What is the current status of trial NCT04926857?
This trial is currently terminated. The enrollment target is 973 participants. The study started on 2021-06-21. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT04926857?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT04926857?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.